Jung Gum Mo, Lee Seung Hyun, Myung Dae Seong, Lee Wan Sik, Joo Young Eun, Jung Mi Ran, Ryu Seong Yeob, Park Young Kyu, Cho Sung Bum
Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Korea.
Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
J Gastric Cancer. 2018 Mar;18(1):37-47. doi: 10.5230/jgc.2018.18.e2. Epub 2018 Feb 20.
The endoscopic management of a fully covered self-expandable metal stent (SEMS) has been suggested for the primary treatment of patients with anastomotic leaks after total gastrectomy. Embedded stents due to tissue ingrowth and migration are the main obstacles in endoscopic stent management.
The effectiveness and safety of endoscopic management were evaluated for anastomotic leaks when using a benign fully covered SEMS with an anchoring thread and thick silicone covering the membrane to prevent stent embedding and migration. We retrospectively reviewed the data of 14 consecutive patients with gastric cancer and anastomotic leaks after total gastrectomy treated from January 2009 to December 2016.
The technical success rate of endoscopic stent replacement was 100%, and the rate of complete leaks closure was 85.7% (n=12). The mean size of leaks was 13.1 mm (range, 3-30 mm). The time interval from operation to stent replacement was 10.7 days (range, 3-35 days) and the interval from stent replacement to extraction was 32.3 days (range, 18-49 days). The complication rate was 14.1%, and included a single jejunal ulcer and delayed stricture at the site of leakage. No embedded stent or migration occurred. Two patients died due to progression of pneumonia and septic shock 2 weeks after stent replacement.
A benign fully covered SEMS with an anchoring thread and thick membrane is an effective and safe stent in patients with anastomotic leaks after total gastrectomy. The novelty of this stent is that it provides complete prevention of stent migration and embedding, compared with conventional fully covered SEMS.
有人提出采用全覆膜自膨式金属支架(SEMS)进行内镜治疗,作为全胃切除术后吻合口漏患者的主要治疗方法。组织向内生长和支架移位导致的支架嵌入是内镜支架治疗的主要障碍。
当使用带有锚定线和覆盖膜的厚硅胶的良性全覆膜SEMS来预防支架嵌入和移位时,评估内镜治疗吻合口漏的有效性和安全性。我们回顾性分析了2009年1月至2016年12月期间连续治疗的14例全胃切除术后胃癌合并吻合口漏患者的数据。
内镜支架置换的技术成功率为100%,完全闭合漏口的比例为85.7%(n = 12)。漏口的平均大小为13.1毫米(范围3 - 30毫米)。从手术到支架置换的时间间隔为10.7天(范围3 - 35天),从支架置换到取出的间隔为32.3天(范围18 - 49天)。并发症发生率为14.1%,包括1例空肠溃疡和漏口部位的迟发性狭窄。未发生支架嵌入或移位。2例患者在支架置换2周后因肺炎进展和感染性休克死亡。
带有锚定线和厚膜的良性全覆膜SEMS对于全胃切除术后吻合口漏患者是一种有效且安全的支架。与传统的全覆膜SEMS相比,这种支架的新颖之处在于它能完全防止支架移位和嵌入。